Alzheimer's drug rules reviewed

PLANS to restrict certain Alzheimer's drugs on the NHS are to be reviewed after a landmark ruling by the Court of Appeal.

Three judges found the decision to restrict anti-dementia medicines for newly diagnosed patients with mild Alzheimer's was procedurally unfair. Pharmaceutical firms said the ruling brought renewed hope for patients.